DR. DEVESH SRIVASTAVA
Dr. Devesh Srivastava provides deep knowledge and insight from years in private practice, as in-house counsel, and as an Examiner at the U.S. Patent and Trademark Office (USPTO). With this experience, he assists companies and universities active in biological, pharmaceutical, chemical, and agricultural technologies to achieve their intellectual property and business goals. He is active in coordinating international patent strategy, patent opinions and counseling, licensing negations and agreements, due diligence associated with collaborations and asset acquisition, and patent prosecution.
Dr. Srivastava’s in-house experience extends from large corporate settings to nimble start-ups. Prior to working at Grüneberg and Myers, Dr. Srivastava worked as in-house counsel at one of the world’s largest chemical companies. There, his responsibilities included worldwide transactions in patent-related matters, focusing on medical diagnostics, agricultural products, and agricultural biotechnology. Beyond his experience in a larger corporate setting, Dr. Srivastava has also served as Head IP Counsel for a start-up company working in cancer therapeutics, endocrine technologies, and diagnostics. In the start-up environment, he covered all aspects of the company’s global intellectual property strategy, handling aspects such as IP strategy and policy, licensing, clinical trial agreements, and due diligence.
Through the course of his career in patent law, Dr. Srivastava has strategized and managed global patent portfolios for developmental and commercial products, and has collaborated with teams that successfully defended patents in Australia, Europe and the United States. His skills further cover confidentiality agreements, university technology transfer, and regulatory law, including FDA and USDA matters.
In addition to his experience in private and in-house practice, Dr. Srivastava served at the USPTO as an Examiner in complex biotechnological and pharmaceutical fields. From his own experience, he understands the mindset of Examiners in quickly-developing areas within the life sciences. Equipped with this perspective, Dr. Srivastava can guide applications efficiently through prosecution to provide valuable protection.
Dr. Srivastava completed his Ph.D. in Physiological Optics and Vision Science at the University of Houston, where he studied the effects of lead exposure on second messenger systems in photoreceptors. Afterwards, he completed a post-doctoral fellowship at the Wilmer Eye Institute at The Johns Hopkins University School of Medicine, where he investigated the role of growth factors in retinal development and disease. He was also a Visiting Scholar at The Jules Stein Eye Institute at the UCLA School of Medicine.
Dr. Srivastava has published in peer-reviewed scientific and legal journals, among them Toxicology Letters and Biochemical Journal. He held his own research funding as a graduate student and post-doctoral fellow. He has written a scientific book chapter, and has been an invited speaker at scientific conferences, the Association of University Technology Managers, and at legal education conferences. He is an inventor on a number of U.S. and foreign patents. Outside of his career in patent law, he enjoys playing competitive tennis.
University of Maryland School of Law
University of Houston
Ph.D., Physiological Optics and Vision Science
University of Missouri
B.A., Biological Sciences
Admissions and Registrations
• District of Columbia
• U.S. Patent and Trademark Office
Activities & Affiliations
• Phi Delta Phi International Legal Fraternity
• GuidePoint Global Advisors